Dubai, UAE: The Dubai Health Authority (DHA) has announced that it has adopted the Pharmaceutical Track and Trace System, which aims to monitor medication from when they are at manufacturing companies (in the UAE or abroad) until they reach the patient.
The DHA is the first organization to adopt this system in the UAE, which complements the barcoding system adopted by the authority in 2017.
The authority has announced that it will start implementing the new system to track and trace medication mid next year adding that it has started discussions a few days ago with big manufacturing and supplying pharmaceutical companies to implement the system, which aims to achieve the highest standards of safety and quality.
The DHA stressed that the Track and Trace System helps combat potential counterfeit medication and ensures accuracy and credibility with regards to insurance claims for dispensing medications. The system also contributes to improving the management of medication inventory in Dubai and helps avoid any medication shortage.
His Excellency Humaid Al Qutami, Director General of the DHA that the authority prioritizes pharmaceutical services and so spares no effort in developing pharmaceutical services by adopting the latest technologies and smart systems to ensure the safety and supply of medication as this directly affects the treatment journey of patients and their wellbeing.
Al Qutami highlighted some of the latest smart technologies and systems adopted for pharmaceutical services including the barcode smart system. The DHA was the first in the UAE to adopt the system in 2017, which aims to ensure the safety of patients by giving each medicine a barcode, hence reducing the chances of any mistakes when dispensing medication.
The authority has adopted a smart system that monitors the cold chain of pharmaceuticals to preserve the quality and safety of medication.
The DHA has also launched a number smart pharmacies across its facilities for dispensing and prescribing medication.
Dr Ali Al Sayed, the Director of the Pharmaceutical Services Department at the DHA said the DHA constantly works on developing its pharmaceutical services to provide quality services for patients and to achieve customer satisfaction.
He added that the authority has a clear plan to continue on adopting the best and latest systems and technologies and to meet the highest international standards to ensure the safety and welbing of customers.
-Ends-
For further information, please contact:
Kamakshi Gupta and Noor Nazzal
Communications Analysts- Media Dept.
Dubai Health Authority
klgupta@dha.gov.ae nnnazzal@dha.gov.ae
+9714 2197455
About the Dubai Health Authority:
The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement.
Prior to the establishment of the DHA, the Department of Health and Medical Services, which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.
In May 2018, H.H Sheikh Mohammed, issued Law No. (6) of 2018 of the DHA. The new Law further enables the DHA to achieve its objectives including regulating medical services in Dubai, enhancing competiveness and transparency, improving medical services and products based on international best practices and achieving the sector’s objectives according to approved strategic plans.
H.H Sheikh Mohammed also issued Decree No. 17 of 2018 establishing subsidiaries of the DHA: the Dubai Healthcare Corporation and Dubai Health Insurance Corporation to further enhance healthcare services in Dubai and enable DHA to fulfil its responsibilities and obligations.
Three new strategic sectors were also added as part of the decree; they include Strategy and Corporate Development, Health Regulation, and Shared Support Services.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including Latifa, Dubai, Rashid and Hatta Hospitals, its 12 primary healthcare centres, 17 medical fitness centres and its 6 specialty centres.
For more information, visit DHA’s website: www.dha.gov.ae
© Press Release 2019Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
